; Healthcare, Regulatory and Reimbursement Landscape – Taiwan
Learning Center
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Healthcare, Regulatory and Reimbursement Landscape – Taiwan


ReportsnReports adds a new report "Healthcare, regulatory and reimbursement landscape – taiwan" to its research database.

More Info
  • pg 1
									            Healthcare, Regulatory and
        Reimbursement Landscape – Taiwan
It is an essential source of information and analysis on Taiwan’s healthcare, regulatory and reimbursement
landscape. It identifies the key trends in the healthcare market and provides insights into the demographic,
regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, the report
provides valuable insights into the trends and segmentation of the pharmaceutical and medical device
markets. It is built using data and information sourced from proprietary databases, secondary research and
in-house analysis by GlobalData’s team of industry experts. Taiwan had a population of approximately 23.2
million in 2010, having increased at a Compound Annual Growth Rate (CAGR) of 0.3% from 2005.
Approximately 75% of the population lives in cities, of which Taipei, Keelung, Kaohsiung and Taichung are
the most populated. In 2007, the country had a population density of 632 people per square kilometer, the
second highest among countries with a population of more than 10 million. Taiwan’s pharmac eutical market
was worth $3.7 billion in 2010, having grown at a CAGR of 2.6% from 2010. Although smaller than India’s
pharmaceutical market, worth $12.9 billion, Taiwan’s per capita expenditure on medicines was significantly
higher, at $160 compared to India’s $106. The market for medical devices in Taiwan is one of the largest in
Asia. It was valued at approximately $1.6 billion in 2006 and grew at a CAGR of 5.1% to $1.9 billion in
2011. It is predicted to reach $3 billion by 2020. These positive trends can primarily be attributed to:
Growing elderly population Universal healthcare insurance High degree of access to healthcare facilities

Get your copy of this report @

Report Details:
Published: September 2012
Price: Single User License: US$3995            Corporate User License: US$15980


       Overview of Taiwan’s pharmaceutical and medical device markets, including size, segmentation
        and key drivers and barriers
       Profiles and SWOT analyses of the major players in the pharmaceutical and medical device
       Insightful review of the reimbursement and regulatory landscape, comprising details of the
        healthcare reimbursement process, regulatory agencies and approval processes for new drugs
        and medical devices
       Detailed analysis of Taiwan’s political and economic environment, including economic indicators,
        demographics, healthcare infrastructure and healthcare expenditure
       An overview of the opportunities for and challenges to growth in the healthcare market

Reasons To Buy
       Develop business strategies by understanding the trends shaping and driving Taiwan’s healthcare
       Drive revenues by understanding         key trends, reimbursement and         regulatory policies,
        pharmaceutical and medical device market segments and companies likely to impact the
        healthcare market in the future
       Formulate effective sales and marketing strategies by understanding the competitive landscape
        and analyzing the performance of various competitors
       Organize your sales and marketing efforts by identifying the market categories and segments that
        present the most opportunities for consolidation, investment and strategic partnerships
       Identify, understand and capitalize on the opportunities and challenges in Taiwan’s healthcare

Get reports related to Healthcare@ http://www.reportsnreports.com/market-

Contact sales@reportsandreports for further information.

To top